Seizing child recieving IN treatmentTherapeutic Intranasal Drug Delivery

Needleless treatment options for medical problems

(Scroll down if the text is missing on your screen)

Why you should consider intranasal drug administration as another option for delivering medications to patients:

Acute seizures, narcotic overdose, severe hypoglycemia, procedural sedation, and acute and chronic pain control are all complex medical problems requiring multiple approaches for effective management. Intranasal (IN) drug delivery is emerging as a low-tech, inexpensive and non-invasive first line method for managing these and other medical problems.  Nasal medication delivery takes a middle path between slow onset oral medications and invasive, highly skilled delivery of intravenous medications. Medication deposited on the highly vascular nasal mucosa may be rapidly absorbed into the blood stream and cerebral spinal fluid (CSF), achieving therapeutic drug levels more quickly and predictably than oral medications while avoiding needles. This results in therapeutic drug levels and effective treatment of seizures, pain, anxiety, hypoglycemia, opiate overdose, epistaxis (bloody noses), etc without the need to give a shot or a pill. Because intra-nasal medication delivery is effective using generic medications, it is quite inexpensive, an advantage in this era of increasingly expensive medical technology. This web site offers health care and consumers information about nasal drug therapy: medical research, expert testimonial opinion and protocol suggestions. Major topics reviewed include intranasal midazolam for sedation and seizures, intranasal fentanyl and intranasal sufentanil for acute and chronic pain control, intranasal naloxone for opiate overdoses and intranasal glucagon for hypoglycemia.

Disclaimer: The information on this web site is for educational and informational purposes only. It is not professional medical advice nor is it intended to substitute for such. Most intranasal medication usage is "off label"  (lacking FDA or other government approved indications for intranasal delivery). Clinicians should use this therapy based on patient needs and peer reviewed literature support, realizing that many commonly used medical therapies and medication uses are used "off-label."